| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $-0.1B | $-0.1B | $-0.3B | $0.2B | $-0.3B | $0.2B | — |
| Net Income | $0.1B | $-0.1B | $-0.0B | $-0.3B | $0.2B | $0.1B | $0.1B | $0.0B |
| EPS (Basic) | $1.12 | $-1.14 | $-0.99 | $-0.90 | $0.38 | $0.19 | $0.20 | $0.02 |
| EPS (Diluted) | $1.10 | $-1.14 | $-0.99 | $-0.90 | $0.38 | $0.18 | $0.20 | $0.02 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.6B | $9.2B | $7.4B | $6.2B | $5.6B | $4.7B | $0.5B | $14.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.2B | $0.2B | $0.2B | $0.3B | $0.3B | $0.1B | $0.1B |
| Total Liabilities | $11.2B | $7.8B | $5.8B | $4.4B | $3.2B | $2.3B | $21.3B | $13.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $1.4B | $1.6B | $1.8B | $2.3B | $2.3B | $-0.1B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B |
| Investing Cash Flow | $-2.9B | $-2.2B | $-1.2B | $-0.5B | $-0.1B | $2.1B | $-0.8B | $-0.6B |
| Capital Expenditures | $0.0B | $0.0B | $0.1B | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $2.8B | $2.2B | $1.1B | $0.5B | $0.0B | $-2.0B | $0.7B | $0.6B |